Literature DB >> 17961987

Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection.

Rajiv P Sharma1, Dennis R Grayson, David P Gavin.   

Abstract

Histone deactylase enzymes are responsible for the deacetylation of histone tails, and consequently influence gene regulation through their ability to modify chromatin structure surrounding promoter regions. We analyzed the microarray collection of the National Brain Databank to investigate differential expression of these enzymes in the prefrontal cortices of control, schizophrenia and bipolar subjects. HDAC1 expression levels were significantly higher in schizophrenia versus normal subjects. The mRNA expression level of an epigenetically regulated schizophrenia candidate gene GAD67 was strongly and negatively correlated with the mRNA expression levels of HDAC1, HDAC3 and HDAC4 levels. These findings provide additional support for the proposal that epigenetic factors are operative in the brain pathology of patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17961987      PMCID: PMC2254186          DOI: 10.1016/j.schres.2007.09.020

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  33 in total

1.  Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus.

Authors:  Jonathan M Levenson; Tania L Roth; Farah D Lubin; Courtney A Miller; I-Chia Huang; Priyanka Desai; Lauren M Malone; J David Sweatt
Journal:  J Biol Chem       Date:  2006-04-10       Impact factor: 5.157

2.  Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.

Authors:  Hamid Mostafavi Abdolmaleky; Kuang-Hung Cheng; Stephen V Faraone; Marsha Wilcox; Stephen J Glatt; Fangming Gao; Cassandra L Smith; Rahim Shafa; Batol Aeali; Julie Carnevale; Hongjie Pan; Panagiotis Papageorgis; Jose F Ponte; Vadivelu Sivaraman; Ming T Tsuang; Sam Thiagalingam
Journal:  Hum Mol Genet       Date:  2006-09-19       Impact factor: 6.150

3.  Covalent modification of DNA regulates memory formation.

Authors:  Courtney A Miller; J David Sweatt
Journal:  Neuron       Date:  2007-03-15       Impact factor: 17.173

4.  S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis.

Authors:  Alessandro Guidotti; William Ruzicka; Dennis R Grayson; Marin Veldic; Graziano Pinna; John M Davis; Erminio Costa
Journal:  Neuroreport       Date:  2007-01-08       Impact factor: 1.837

5.  Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder.

Authors:  Marin Veldic; Bashkim Kadriu; Ekrem Maloku; Roberto C Agis-Balboa; Alessandro Guidotti; John M Davis; Erminio Costa
Journal:  Schizophr Res       Date:  2007-01-31       Impact factor: 4.939

6.  DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes.

Authors:  Marija Kundakovic; Ying Chen; Erminio Costa; Dennis R Grayson
Journal:  Mol Pharmacol       Date:  2006-10-25       Impact factor: 4.436

7.  Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action.

Authors:  Nadia M Tsankova; Olivier Berton; William Renthal; Arvind Kumar; Rachel L Neve; Eric J Nestler
Journal:  Nat Neurosci       Date:  2006-02-26       Impact factor: 24.884

8.  Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population.

Authors:  Rajiv P Sharma; Cherise Rosen; Saritha Kartan; Alessandro Guidotti; Erminio Costa; Dennis R Grayson; Kayla Chase
Journal:  Schizophr Res       Date:  2006-09-25       Impact factor: 4.939

9.  Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection.

Authors:  W B Ruzicka; A Zhubi; M Veldic; D R Grayson; E Costa; A Guidotti
Journal:  Mol Psychiatry       Date:  2007-01-30       Impact factor: 15.992

10.  Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars.

Authors:  Francine M Benes; Benjamin Lim; David Matzilevich; John P Walsh; Sivan Subburaju; Martin Minns
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-06       Impact factor: 11.205

View more
  77 in total

1.  Association study of H2AFZ with schizophrenia in a Japanese case-control sample.

Authors:  Daisuke Jitoku; Naoki Yamamoto; Yoshimi Iwayama; Tomoko Toyota; Momo Miyagi; Takeshi Enokida; Yuri Tasaka; Masakazu Umino; Asami Umino; Akihito Uezato; Yasuhide Iwata; Katsuaki Suzuki; Mitsuru Kikuchi; Tasuku Hashimoto; Nobuhisa Kanahara; Akeo Kurumaji; Takeo Yoshikawa; Toru Nishikawa
Journal:  J Neural Transm (Vienna)       Date:  2014-11-13       Impact factor: 3.575

Review 2.  Genetic variation in the epigenetic machinery and mental health.

Authors:  Chris Murgatroyd; Dietmar Spengler
Journal:  Curr Psychiatry Rep       Date:  2012-04       Impact factor: 5.285

Review 3.  Epigenetic GABAergic targets in schizophrenia and bipolar disorder.

Authors:  A Guidotti; J Auta; Y Chen; J M Davis; E Dong; D P Gavin; D R Grayson; F Matrisciano; G Pinna; R Satta; R P Sharma; L Tremolizzo; P Tueting
Journal:  Neuropharmacology       Date:  2010-11-11       Impact factor: 5.250

4.  Proteomics for Target Identification in Psychiatric and Neurodegenerative Disorders.

Authors:  André S L M Antunes; Valéria de Almeida; Fernanda Crunfli; Victor C Carregari; Daniel Martins-de-Souza
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Differences in 5-HT2A and mGlu2 Receptor Expression Levels and Repressive Epigenetic Modifications at the 5-HT2A Promoter Region in the Roman Low- (RLA-I) and High- (RHA-I) Avoidance Rat Strains.

Authors:  Luna Fomsgaard; Jose L Moreno; Mario de la Fuente Revenga; Tomasz Brudek; Dea Adamsen; Cristobal Rio-Alamos; Justin Saunders; Anders Bue Klein; Ignasi Oliveras; Toni Cañete; Gloria Blazquez; Adolf Tobeña; Albert Fernandez-Teruel; Javier Gonzalez-Maeso; Susana Aznar
Journal:  Mol Neurobiol       Date:  2017-03-06       Impact factor: 5.590

Review 6.  Acetyltransferases (HATs) as targets for neurological therapeutics.

Authors:  Anne Schneider; Snehajyoti Chatterjee; Olivier Bousiges; B Ruthrotha Selvi; Amrutha Swaminathan; Raphaelle Cassel; Frédéric Blanc; Tapas K Kundu; Anne-Laurence Boutillier
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

7.  Exposure to caregiver maltreatment alters expression levels of epigenetic regulators in the medial prefrontal cortex.

Authors:  Jennifer Blaze; Tania L Roth
Journal:  Int J Dev Neurosci       Date:  2013-10-10       Impact factor: 2.457

8.  Evidence of a sex-dependent restrictive epigenome in schizophrenia.

Authors:  Kayla A Chase; Cherise Rosen; Leah H Rubin; Benjamin Feiner; Anjuli S Bodapati; Hannah Gin; Edward Hu; Rajiv P Sharma
Journal:  J Psychiatr Res       Date:  2015-04-18       Impact factor: 4.791

Review 9.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

10.  Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures.

Authors:  David P Gavin; Cherise Rosen; Kayla Chase; Dennis R Grayson; Nguwah Tun; Rajiv P Sharma
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.